Search research articles
Contact Us
Filters
Showing results (11-20 of 155) with videos related to
Page
of 16
Sort By:
Kidney International. Supplement
|
August 4, 2007
The role of protein kinase C activation in diabetic nephropathy
H Noh, G L King
The Journal of Clinical Investigation
|
May 26, 2001
Can VEGF reverse diabetic neuropathy in human subjects?
A Veves, G L King
Diabetes Care
|
April 6, 1999
Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes
G L King, H Wakasaki
Endocrinology and Metabolism Clinics of North America
|
June 1, 1996
The cellular and molecular mechanisms of diabetic complications
G L King, M Brownlee
Vascular Medicine (London, England)
|
December 5, 2000
Protein kinase C activation and its pharmacological inhibition in vascular disease
M Meier, G L King
Diabetes
|
May 30, 1998
Protein kinase C activation and the development of diabetic complications
D Koya, G L King
Clinical Chemistry
|
February 5, 2000
The potential use of glutathionyl hemoglobin as a clinical marker of oxidative stress
S E Bursell, G L King
Journal of Animal Science
|
March 1, 1981
Wheat shorts in diets of gestating swine
L G Young, G L King
The American Journal of Physiology
|
August 1, 1992
Surgical and pharmacological dissociation of cardiovascular and emetic responses to intragastric CuSO4
M T Makale, G L King
Brain Research
|
December 7, 1981
Extracellular calcium and action potentials of soma and dendrites of hippocampal pyramidal cells
G L King, G G Somjen
Page
of 16
Search research articles
Search
Showing results (11-20 of 155) with videos related to
Sort By:
Page
of 16
Kidney International. Supplement
|
August 4, 2007
The role of protein kinase C activation in diabetic nephropathy
H Noh, G L King
The Journal of Clinical Investigation
|
May 26, 2001
Can VEGF reverse diabetic neuropathy in human subjects?
A Veves, G L King
Diabetes Care
|
April 6, 1999
Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes
G L King, H Wakasaki
Endocrinology and Metabolism Clinics of North America
|
June 1, 1996
The cellular and molecular mechanisms of diabetic complications
G L King, M Brownlee
Vascular Medicine (London, England)
|
December 5, 2000
Protein kinase C activation and its pharmacological inhibition in vascular disease
M Meier, G L King
Diabetes
|
May 30, 1998
Protein kinase C activation and the development of diabetic complications
D Koya, G L King
Clinical Chemistry
|
February 5, 2000
The potential use of glutathionyl hemoglobin as a clinical marker of oxidative stress
S E Bursell, G L King
Journal of Animal Science
|
March 1, 1981
Wheat shorts in diets of gestating swine
L G Young, G L King
The American Journal of Physiology
|
August 1, 1992
Surgical and pharmacological dissociation of cardiovascular and emetic responses to intragastric CuSO4
M T Makale, G L King
Brain Research
|
December 7, 1981
Extracellular calcium and action potentials of soma and dendrites of hippocampal pyramidal cells
G L King, G G Somjen
Page
of 16